Published in PLoS One on October 27, 2011
Participants' understanding of informed consent in clinical trials over three decades: systematic review and meta-analysis. Bull World Health Organ (2015) 1.34
An investigation of the efficacy of electronic consenting interfaces of research permissions management system in a hospital setting. Int J Med Inform (2013) 1.11
Could the decision of trial participation precede the informed consent process? Evidence from Burkina Faso. PLoS One (2013) 0.97
Voluntary participation and comprehension of informed consent in a genetic epidemiological study of breast cancer in Nigeria. BMC Med Ethics (2014) 0.91
A pilot study of simple interventions to improve informed consent in clinical research: feasibility, approach, and results. Clin Trials (2014) 0.89
Comparison of closed-ended, open-ended, and perceived informed consent comprehension measures for a mock HIV prevention trial among women in Tanzania. PLoS One (2014) 0.79
A Comparison of the Quality of Informed Consent for Clinical Trials of an Experimental Hookworm Vaccine Conducted in Developed and Developing Countries. PLoS Negl Trop Dis (2017) 0.75
Factors influencing willingness to participate in new drug trial studies: a study among parents whose children were recruited into these trials in northern Ghana. BMC Res Notes (2016) 0.75
Correlates of lower comprehension of informed consent among participants enrolled in a cohort study in Pune, India. Int Health (2012) 0.75
Why female sex workers participate in HIV research: the illusion of voluntariness. AIDS Care (2016) 0.75
Interventions to improve research participants' understanding in informed consent for research: a systematic review. JAMA (2004) 7.97
Readability standards for informed-consent forms as compared with actual readability. N Engl J Med (2003) 7.58
Informed consent -- why are its goals imperfectly realized? N Engl J Med (1980) 6.43
Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet (2001) 6.07
False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep (1987) 5.64
Comprehension during informed consent in a less-developed country. Lancet (2002) 4.46
Informed consent: study of quality of information given to participants in a clinical trial. BMJ (1991) 3.46
Obtaining informed consent to neonatal randomised controlled trials: interviews with parents and clinicians in the Euricon study. Lancet (2000) 3.25
Understanding of informed consent in a low-income setting: three case studies from the Kenyan Coast. Soc Sci Med (2004) 3.20
Communication of randomization in childhood leukemia trials. JAMA (2004) 3.20
Quality of informed consent: a new measure of understanding among research subjects. J Natl Cancer Inst (2001) 2.85
Improvement of informed consent and the quality of consent documents. Lancet Oncol (2008) 2.21
Informed consent for investigational chemotherapy: patients' and physicians' perceptions. J Clin Oncol (1984) 2.12
Enhancing informed consent for research and treatment. Neuropsychopharmacology (2001) 2.04
The informed consent process in a rural African setting: a case study of the Kassena-Nankana district of Northern Ghana. IRB (2006) 2.02
Views of US researchers about informed consent in international collaborative research. Soc Sci Med (2005) 2.02
Informed consent to biomedical research in Veterans Administration Hospitals. JAMA (1982) 1.99
Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials. J Clin Oncol (1996) 1.95
Informed consent: how much and what do patients understand? Am J Surg (2009) 1.90
Consent form readability and educational levels of potential participants in mental health research. Psychiatr Serv (2007) 1.89
Lay public's understanding of equipoise and randomisation in randomised controlled trials. Health Technol Assess (2005) 1.88
Is informed consent to clinical trials an "upside selective" process in acute coronary syndromes? Am Heart J (2000) 1.74
Longer consent forms for clinical trials compromise patient understanding: so why are they lengthening? J Clin Oncol (2007) 1.66
Problems in comprehension of informed consent in rural and peri-urban Mali, West Africa. Clin Trials (2006) 1.65
Quantitative analysis of ethical issues in phase I trials: a survey interview of 144 advanced cancer patients. IRB (2001) 1.62
Maintaining informed consent validity during lengthy research protocols. IRB (2008) 1.62
How informed is informed consent? The BHAT experience. Control Clin Trials (1981) 1.55
The length of consent documents in oncological trials is doubled in twenty years. Ann Oncol (2008) 1.54
Beyond the checklist: assessing understanding for HIV vaccine trial participation in South Africa. J Acquir Immune Defic Syndr (2006) 1.51
Informed consent: how much does the patient understand? Clin Pharmacol Ther (1980) 1.50
Clinical research in low-literacy populations: using teach-back to assess comprehension of informed consent and privacy information. IRB (2008) 1.49
Impact of quality of life on patient expectations regarding phase I clinical trials. J Clin Oncol (2000) 1.47
Informed consent in international health research. J Empir Res Hum Res Ethics (2006) 1.46
Isoniazid tuberculosis preventive therapy in HIV-infected adults accessing antiretroviral therapy: a Botswana Experience, 2004-2006. J Acquir Immune Defic Syndr (2010) 1.37
Informed consent for research. Effects of readability, patient age, and education. J Am Geriatr Soc (1986) 1.35
Making consent more informed: preliminary results from a multiple-choice test among probation-referred marijuana users entering a randomized clinical trial. J Am Acad Psychiatry Law (2008) 1.33
Informed consent in Ghana: what do participants really understand? J Med Ethics (2008) 1.32
Parental perceptions and attitudes about informed consent in clinical research involving children. Soc Sci Med (1995) 1.31
Evaluation of the quality of informed consent in a vaccine field trial in a developing country setting. BMC Med Ethics (2008) 1.27
Recall of informed consent information by healthy volunteers in clinical trials. QJM (2008) 1.24
The informed consent process in a cross-cultural setting: is the process achieving the intended result? Ethn Dis (2005) 1.17
Can we ensure that all research subjects give valid consent? Arch Intern Med (2004) 1.16
Informed consent and participant perceptions of influenza vaccine trials in South Africa. J Med Ethics (2005) 1.16
Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military. J Acquir Immune Defic Syndr (2001) 1.16
Post-consent assessment of dental subjects' understanding of informed consent in oral health research in Nigeria. BMC Med Ethics (2009) 1.15
Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.15
Development of a measure of informed choice suitable for use in low literacy populations. Patient Educ Couns (2007) 1.06
Understanding informed consent for participation in international health research. Dev World Bioeth (2008) 1.02
The adequacy of consent forms for informing patients entering oncological clinical trials. Ann Oncol (1995) 1.00
Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand. J Acquir Immune Defic Syndr (1999) 0.99
Research ethics, informed consent, and participant recruitment. Clin Nurse Spec (2004) 0.92
Factual understanding of randomized clinical trials: a multicenter case-control study in cancer patients. Invest New Drugs (2009) 0.90
Developing AIDS vaccine trials educational programs in Uganda. J Acquir Immune Defic Syndr (2001) 0.87
Looking at research consent forms through a participant-centered lens: the PRISM readability toolkit. Am J Health Promot (2009) 0.86
Informed consent for a clinical trial in Thailand. N Engl J Med (1998) 0.85
Proposing phase I studies: patients', relatives', nurses' and specialists' perceptions. Ann Oncol (2000) 0.84
Understanding of placebo controls among older people with schizophrenia. Schizophr Bull (2005) 0.83
Implementation of a multicomponent process to obtain informed consent in the Diabetes Control and Complications Trial. The DCCT Research Group. Control Clin Trials (1989) 0.81
Evaluation of informed consent in health research: a questionnaire survey. Scand J Caring Sci (2009) 0.81
Informed consent: theory versus practice. Nat Clin Pract Cardiovasc Med (2005) 0.80
Screening in the dark: ethical considerations of providing screening tests to individuals when evidence is insufficient to support screening populations. Am J Bioeth (2009) 5.89
Public health ethics: mapping the terrain. J Law Med Ethics (2002) 5.29
An ethics framework for a learning health care system: a departure from traditional research ethics and clinical ethics. Hastings Cent Rep (2013) 5.27
The research-treatment distinction: a problematic approach for determining which activities should have ethical oversight. Hastings Cent Rep (2013) 4.69
Informed consent, comparative effectiveness, and learning health care. N Engl J Med (2014) 3.97
Incidence of hepatitis A in the United States in the era of vaccination. JAMA (2005) 2.42
Views of US researchers about informed consent in international collaborative research. Soc Sci Med (2005) 2.02
"You've got to understand community": community perceptions on "breaking the disconnect" between researchers and communities. Prog Community Health Partnersh (2007) 1.82
The OHRP and SUPPORT. N Engl J Med (2013) 1.78
Human rights, politics, and reviews of research ethics. Lancet (2002) 1.77
What patients say about medical research. IRB (1999) 1.63
The ethics of contact tracing programs and their implications for women. Duke J Gend Law Policy (1998) 1.50
A study to evaluate the effect of investigator attendance on the efficiency of IRB review. IRB (2008) 1.42
Isoniazid tuberculosis preventive therapy in HIV-infected adults accessing antiretroviral therapy: a Botswana Experience, 2004-2006. J Acquir Immune Defic Syndr (2010) 1.37
Participation in pedigree studies and the risk of impeded access to health insurance. IRB (1994) 1.24
Disclosure, confidentiality, and families: experiences and attitudes of those with genetic versus nongenetic medical conditions. Am J Med Genet C Semin Med Genet (2003) 1.20
Risk factors for non-adherence and loss to follow-up in a three-year clinical trial in Botswana. PLoS One (2011) 1.15
Assessment of the ethical review process in Sudan. Dev World Bioeth (2007) 1.14
Patients' perceptions of research in emergency settings: a study of survivors of sudden cardiac death. Soc Sci Med (2008) 1.14
Research ethics capacity development in Africa: exploring a model for individual success. Dev World Bioeth (2012) 1.08
Learning health care systems and justice. Hastings Cent Rep (2011) 1.02
Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana. Am J Respir Crit Care Med (2010) 1.01
Research Ethics Consultation at the Johns Hopkins Bloomberg School of Public Health. IRB (2009) 0.94
Our two cents: research ethics consultation at Johns Hopkins Bloomberg School of Public Health. Am J Bioeth (2008) 0.90
Persistence of long-term immunity to hepatitis B among adolescents immunized at birth. Vaccine (2012) 0.89
Informed consent for dementia research: the study enrollment encounter. IRB (2007) 0.89
Informed consent for comparative effectiveness trials. N Engl J Med (2014) 0.89
Forecast for the Physician Payment Sunshine Act: partly to mostly cloudy? Ann Intern Med (2014) 0.89
Systematic review of TST responses in people living with HIV in under-resourced settings: implications for isoniazid preventive therapy. PLoS One (2012) 0.88
On the importance of research ethics and mentoring. Am J Bioeth (2002) 0.87
Assessing the readability of non-English-language consent forms: the case of Kiswahili for research conducted in Kenya. IRB (2010) 0.87
Ethical issues raised in addressing the needs of people with serious mental disorders in complex emergencies. Disaster Med Public Health Prep (2012) 0.86
Disclosure of personal medical information: differences among parents and affected adults for genetic and nongenetic conditions. Genet Test (2005) 0.86
The use of CT for screening: a national survey of radiologists' activities and attitudes. Radiology (2008) 0.85
Are research subjects adequately protected? A review and discussion of studies conducted by the Advisory Committee on Human Radiation Experiments. Kennedy Inst Ethics J (1996) 0.84
Development of a research ethics knowledge and analytical skills assessment tool. J Med Ethics (2011) 0.83
The ethical review of health care quality improvement initiatives: findings from the field. Issue Brief (Commonw Fund) (2010) 0.81
The influence of HIV serostatus on physicians' clinical decisions. AIDS Public Policy J (1994) 0.80
Challenges for mental health services raised by disaster preparedness: mapping the ethical and therapeutic terrain. Biosecur Bioterror (2011) 0.79
Building trust for engagement of minorities in human subjects research: is the glass half full, half empty, or the wrong size? Am J Public Health (2013) 0.79
Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana. J Acquir Immune Defic Syndr (2015) 0.79
Pregnancy outcomes in HIV-infected women receiving long-term isoniazid prophylaxis for tuberculosis and antiretroviral therapy. Infect Dis Obstet Gynecol (2013) 0.78
Evaluating international research ethics capacity development: an empirical approach. J Empir Res Hum Res Ethics (2014) 0.78
Ethical Issues in Patient Safety Research: A Systematic Review of the Literature. J Patient Saf (2015) 0.78
Isoniazid-associated hepatitis in adults infected with HIV receiving 36 months of isoniazid prophylaxis in Botswana. Chest (2015) 0.77
Rapid estimate of adult literacy in medicine: feasible by telephone? Fam Med (2010) 0.76
Response to open peer commentaries for "Ethical considerations of providing screening tests to individuals when evidence is insufficient to support screening populations". Am J Bioeth (2009) 0.75
The proportions of people living with HIV in low and middle-income countries who test tuberculin skin test positive using either a 5 mm or a 10 mm cut-off: a systematic review. BMC Infect Dis (2013) 0.75
Attending to local justice: lessons from pediatric HIV. IRB (2003) 0.75
A Journey in Public Health Ethics. Perspect Biol Med (2017) 0.75
Policy options for prenatal screening programs for HIV: the preferences of inner-city pregnant women. AIDS Public Policy J (1992) 0.75
Incidence of Hepatitis C Virus Infection in the Human Immunodeficiency Virus Outpatient Study Cohort, 2000-2013. Open Forum Infect Dis (2017) 0.75